With 30-year in­dus­try chops, Pamela Con­ley launch­es a pro­tein ther­a­peu­tics biotech for au­toim­mune dis­eases

Af­ter about 17 years at Por­to­la Phar­ma­ceu­ti­cals, Pamela Con­ley was ready for her next ven­ture once help­ing tran­si­tion some of the drug­mak­er’s pro­grams in­to Alex­ion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER